CBI.TA TLV
Clal Biotechnology Industries Ltd.
1W: +3.9%
1M: +4.8%
3M: -6.6%
YTD: -23.7%
1Y: -23.4%
3Y: -60.3%
5Y: -84.5%
₪24.20 ($0.08)
+0.50 (+2.11%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$6M
+23.9% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$6M
+23.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
-3.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $109M | -$128M | -$95M | -$28M | -$75M |
| Depreciation & Amort. | $24M | $23M | $18M | $526K | $283K |
| Stock-Based Comp. | $6M | $6M | $5M | $40K | $0 |
| Change in Working Capital | -$2M | $2M | -$20M | $1M | -$51K |
| Other Non-Cash Items | -$62M | $559K | $3M | $18M | $68M |
| Operating Cash Flow | -$33M | -$41M | -$59M | -$9M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$2M | -$1M | -$5K | $0 |
| Acquisitions (Net) | -$1M | -$13M | -$13M | $3M | -$401K |
| Investment Purchases | -$390K | -$4M | -$10M | -$1M | $0 |
| Investment Sales | $74M | $98M | $13M | $5M | $18M |
| Other Investing | $1M | $118K | $15K | $825K | $3M |
| Investing Cash Flow | $71M | $79M | -$11M | $8M | $20M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$2M | -$2M | -$3M | -$1M | -$11M |
| Stock Repurchased | -$256K | -$10M | $0 | $0 | $0 |
| Dividends Paid | $0 | -$36M | $0 | $0 | $0 |
| Other Financing | -$934K | -$4M | -$1M | -$247K | -$5M |
| Financing Cash Flow | -$2M | -$52M | $20M | -$1M | -$16M |
| Net Change in Cash | $31M | -$15M | -$46M | -$2M | -$2M |
| Cash End of Period | $68M | $53M | $7M | $6M | $4M |
| Free Cash Flow | -$36M | -$43M | -$60M | -$9M | -$6M |